MariMed Inc.
MRMD.CN
Canadian Securities Exchange0.10
CAD
- -
- -
MariMed Inc.
MRMD.CN
(Canadian Securities Exchange)
Recent
price
0.10
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- MariMed Inc. (CSE: MRMD) operates as a leading multi-state cannabis operator in the United States, engaging in the cultivation, production, processing, and retail sale of branded cannabis products for medical and adult-use markets; it develops and manages state-licensed cultivation facilities, production centers, and dispensaries under brands including Thrive Wellness, while licensing its consumer products portfolio nationwide. The company offers cannabis flower, vapes, and concentrates under the Nature’s Heritage brand; fruit chews for sleep, pain relief, and stress under Betty’s Eddies; cannabis-infused ice creams under Emack & Bolio's; soft baked goods and hot chocolate mix under Bubby’s Baked; hydrating drink mixes under Vibations; flower, vapes, and edibles under InHouse; and additional brands such as K Fusion and Kalm Fusion. MariMed conducts operations across states including Illinois, Maryland, Massachusetts, Delaware, Nevada, and Rhode Island, with branded products distributed more broadly through licensing; it was founded in 2011 and maintains headquarters in Norwood, Massachusetts. In recent developments, MariMed closed the acquisition of a second Maryland dispensary, Thrive Wellness in Upper Marlboro, in July 2024, expanding its retail footprint in that high-growth adult-use market to two locations alongside a cultivation and processing facility in Hagerstown; it signed a licensing agreement in July 2025 to distribute Betty’s Eddies in Maine for both adult-use and medical channels, entered a managed services agreement with TILT Holdings for a Pennsylvania cultivation and processing facility plus product licensing ahead of anticipated adult-use sales in 2026, and in October 2025 added a licensing deal with a New York operator for brand distribution starting in 2026 following facility build-out. Subsequent to third-quarter 2025 earnings, the company exited the Missouri market in October 2025 by ceasing management of a third-party operator and entered manufacturing, wholesale, and marketing agreements in November 2025 to launch hemp-derived THC products, starting with Vibations drink mix for Rhode Island distribution in early 2026; it also introduced a limited-edition Cranberry Orange fruit chew under Betty’s Eddies in November 2025. These moves support MariMed’s "Expand the Brand" strategy, emphasizing wholesale growth, national licensing, and operational efficiencies amid sequential revenue increases to $40.8 million in Q3 2025.
MariMed Reports First Quarter 2026 Earnings